Infectious diseases have been causing epidemics in our communities since ancient times, so why are they such a popular topic these days? One of the main reasons they’ve been on everyone’s minds lately is due to the COVID-19 outbreak. Since its rise in early 2020, COVID-19 has affected every person in one way or another and does not seem to be stopping anytime soon. Unfortunately, COVID-19 is not alone in its category. There are a multitude of infectious diseases that are equally as capable, in particular viral diseases, that are continuing to emerge. Leinco Technologies understands that research is critical to understanding and managing these diseases.
Explore our infectious disease resources.
Our infectious disease antibodies and proteins catalog includes monoclonal and polyclonal antibodies and a range of recombinant antibodies. We also have several recombinant proteins and blocking peptides to help advance your infectious disease research. Shop our current catalog of infectious disease antibodies and proteins.
Related Resources
Why choose Leinco Technologies?
Research is now more imperative than ever. It’s important that companies can be trusted when providing components for research, particularly with infectious disease antibodies. For years, Leinco Technologies has built a reputation of developing and providing an array of high purity proteins, antibodies and other reagents required to carry out research and diagnostic assays on infectious diseases. Our products are purified with the utmost accuracy and precision, and we understand the importance of repeatable results.